Who
Christopher M. Hall
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Personalis; President and COO, Veracyte; Chief Business Officer, Celera.
In numbers
- Trades disclosed
- 125
- Buys
- 0
- Sells
- 24
- Bought
- $0
- Sold
- $15.4M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 12 Aug 2009
- Last trade
- 18 Sep 2026
- Last filed
- 22 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 22 Sep 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $121K7,459 at $16.22 | filing |
| 18 Sep 2026filed 22 Sep 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $121K7,459 at $16.22 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $161K100,000 at $1.61 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1.5M100,000 at $15.08 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —66,667 at $0.00 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —66,667 at $0.00 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —33,333 at $0.00 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —33,333 at $0.00 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $161K100,000 at $1.61 | filing |
| 9 Jul 2026filed 9 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1.5M100,000 at $15.08 | filing |
| 26 Jun 2026filed 26 Jun 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $161K100,000 at $1.61 | filing |
| 26 Jun 2026filed 26 Jun 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1.3M100,000 at $13.15 | filing |
| 26 Jun 2026filed 26 Jun 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 26 Jun 2026filed 26 Jun 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 26 Jun 2026filed 26 Jun 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $161K100,000 at $1.61 | filing |
| 26 Jun 2026filed 26 Jun 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1.3M100,000 at $13.15 | filing |
| 29 May 2026filed 29 May 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $129K80,091 at $1.61 | filing |
| 29 May 2026filed 29 May 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —80,091 at $0.00 | filing |
| 29 May 2026filed 29 May 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $883K80,091 at $11.02 | filing |
| 29 May 2026filed 29 May 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —80,091 at $0.00 | filing |
News
Critical Analysis: Bionano Genomics (NASDAQ:BNGO) & Personalis (NASDAQ:PSNL)PSNL · tickerreport.com · 24 Oct 2026PSNL Securities Notice: Personalis, Inc. Shareholders Are Notified to Contact BFA Law About Its Pending Investigation into the $16.25 per Share Merger DealPSNL · northernnews.ca · 22 Oct 2026Comparing Bruker (NASDAQ:BRKR) and Personalis (NASDAQ:PSNL)PSNL · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Christopher M. Hall; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.